Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 32
Selected: 0
NCT IDTitle
NCT02796274Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON)
NCT00537680Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia
NCT00697073Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients
NCT04381091Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the LEROS Study
NCT00887562Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes
NCT03680365Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
NCT06689527Evaluation of Vamorolone CYP3A4 Induction on Midazolam (a Sensitive CYP 3A4 Substrate) Pharmacokinetics
NCT00993967Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension)
NCT06713135A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy
NCT00758225Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)
NCT05185622A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)
NCT00905268A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients
NCT01421381RHODOS Follow-up Single-visit Study
NCT01805024Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO)
NCT00758849Fipamezole in Neurogenic Orthostatic Hypotension
NCT02814019A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
NCT01027884Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
NCT02887443A Study to Assess the Potential for Pre-systemic Inhibition of CYP3A by Idebenone Using Midazolam as a Substrate
NCT03748199Clinical Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of POL6014 in Patients With CF
NCT01303406Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI)
NCT03863119Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy
NCT00654784Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy
NCT01892943Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey
NCT02771379Post Authorisation Safety Study With Raxone in LHON Patients
NCT00747487Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy
NCT02774005Study to Assess the Efficacy and Safety of Raxone in LHON Patients
NCT01495715Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
NCT06649409Evaluation of Vamorolone Mineralocorticoid Receptor Antagonism in Healthy Subjects
NCT03603288Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)
NCT03433807Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)
NCT05166109A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)
NCT00559871Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease